News and blogs
346 results found.
Mpox (monkeypox) and blood cancer
Find out about mpox, how it spreads, signs and symptoms, cases in the UK, and what it means for people with blood cancer.
Our Blood Cancer Action Plan to tackle blood cancer survival in the UK
Blood Cancer UK releases its comprehensive Action Plan "Taking blood cancer out of the shadows: A plan to increase survival in the UK"
Wales lags behind England in blood cancer survival
Our press release on our Blood Cancer Action Plan reveals how Wales is lagging behind England when it comes to blood cancer survival. Our landmark report is available to download in English and Welsh.
Interferon supplies for people with MPNs (Pegasys)
Find out what Blood Cancer UK is doing to solve the UK shortage of pegylated interferon alfa 2a (Pegasys), and what you can do if you take Pegasys to treat an MPN.
Ellie's blood cancer story
Ellie lived with acute myeloid leukaemia (AML). Her family are encouraging people to donate towards life-saving research.
Take at home tablet approved for blood cancer on NHS England
Zanubrutinib, is now available on the NHS in England for those with a type of blood cancer called marginal zone lymphoma.,
Drug, dasatinib approved for use on the NHS in Scotland
Dasatinib, is now approved for the treatment of adults with a form of leukaemia - Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukaemia (ALL) - on the NHS in Scotland.
New class of drug approved for myeloma in England and Wales
The very first bispecific drug for myeloma, elranatamab has been approved for restricted use in England and Wales as a fourth-line treatment.
New blood test for myeloma being researched at Birmingham
Two doctors at the University of Birmingham are developing a new technique to help diagnose and monitor people with the blood cancer, non-measurable myeloma.
Scotland approves two new blood cancer drugs
Two new drugs for the blood cancer, diffuse large B-cell lymphoma DLBCL have been made available for use on the NHS in Scotland as a third-line treatment.
Blood cancer treatment for a form of acute myeloid leukaemia approved for use on NHS
New blood cancer treatment for acute myeloid leukaemia (AML) with IDH1 mutation. The National Institute for Health and Care Excellence (NICE) approved Ivosidenib (Tibsovo) with azacitidine has made it available to those in England and Wales.
What's the latest evidence regarding COVID-19 vaccines and blood cancer?
Lots of information continues to circulate about COVID-19 and vaccinations for immunocompromised people. Blood Cancer UK’s Healthcare Professional Advisory Panel (HPAP), made up of specialists from across the UK working in haemato-oncology and related professional fields, has released the statement below to help you understand the latest evidence.
One year later – are we still on track?
Back in 2022, Blood Cancer UK created a new five-year strategy. We made a commitment back then to shape that strategy alongside the Blood Cancer UK community, and to give regular updates. We're now at the end of year one, so it’s the perfect time to stop, reflect and consider whether we're on track.
Prime Minister recognises blood cancer fundraiser
James Badger, from Harrogate who is raising £300,000 for Blood Cancer UK after his wife passed away from leukaemia has received Prime Minister Rishi Sunak’s Points of Light award.
Snowman author leaves gift to Blood Cancer UK
Blood Cancer UK are one of three charities left a gift in the Will of the author and illustrator Raymond Briggs, CBE.
Selinexor recommended in draft final guidance for myeloma
The drug, selinexor has been recommended by NICE in final draft guidance for use in people with myeloma if previous treatment has failed.
Minreet's marathon for mum with myeloma
Minreet and the Skipping Sikh will run the London Marathon for Blood Cancer UK to give hope to their mum who is receiving treatment for the blood cancer, myeloma
CAR-T therapy Kymriah available for a form of childhood and young-adult leukaemia on the NHS
'Life-changing' blood cancer drug, Kymriah is now available routinely on the NHS for childhood and young-adult B-cell acute lymphoblastic leukaemia on the NHS
How a Yorkshire house led to five pioneering research projects
Last year you raised an incredible £1.95m for Blood Cancer UK in the Omaze Millon Pound House Draw. Find out more about the incredible research projects this is helping to support.
Omaze x Blood Cancer UK Research Fund launched
Blood Cancer UK reveals that the money from their latest partnership with Omaze UK is their largest single donation to date. The money has now been invested into research via the Omaze x Blood Cancer UK Research Fund.
